pharma

Jack Rodolico

The New Hampshire Attorney General’s investigation into marketing practices by large pharmaceutical companies hit a roadblock this week. The Attorney General wants to know if those companies have been deceptively marketing opioids - drugs that have been diverted in mass quantities to fuel addictions and overdoses. But a court order now slows down that process.